All stocks / PVCT
PROVECTUS BIOPHARMACEUTICALS, INC. PVCT
Provectus Biopharmaceuticals (PVCT): no warning signs from our rules in the last 12 months and the latest annual figures in plain language. Each fact links to its SEC filing.
Market listing
- Full name
- PROVECTUS BIOPHARMACEUTICALS INC
- Market tier
- OTCQB
- Trading status
- Active
- Last trade
- 09:31:28
- Website
- www.pvct.com
News headlines
The financial report, and what it means
Annual figures to 2025-12-31- Revenue
- $336,108
- Net loss
- ($5,430,851)
It spends more than it earns
Under strainCustomers paid it $336,108 in the year. It lost $5.4 million. For every $1 that came in, about $17.16 went out.
- Cash and cash equivalents
- $251,291
- Net cash used in operating activities
- ($3,325,991)
The cash could run out soon
Under strainIt had $251,291 in the bank and used about $277,166 a month. At that pace the money lasts less than a month unless it borrows or sells more shares.
- Total assets
- $697,502
- Total liabilities
- $7,000,220
It owes more than it owns
Under strainEverything the company owns adds up to $697,502. Its debts and unpaid bills add up to $7 million. That is about $10.04 owed for every $1 owned.
What this adds up to
3 of 3 checks show strain. It spends more than it earns. The cash could run out soon. It owes more than it owns. These are facts from the company's own reports, not a recommendation.
Signals
Estimated float about 420,279,879 shares as of 2026-11-10: 420,279,879 outstanding minus 0 held by 0 reporting insider(s).
Rule: Estimated: shares outstanding minus the latest holdings insiders reported on Forms 3/4/5. Holders of 5% or more (13D/13G) are not yet subtracted. Source record
Shares outstanding
Source: SEC filingsPrice chart
Chart by TradingView. We do not store or publish prices. Live quote on OTC Markets
Recent filings
Common questions about PVCT
Does PVCT file reports with the SEC?
Yes. Provectus Biopharmaceuticals files with the SEC under company number 0000315545. The most recent filing we hold is a 4 dated 2026-11-16.
Source recordHow many PVCT shares are outstanding?
420,279,879 shares as of 2026-11-10, as reported to the SEC.
Source recordHas PVCT filed reports late?
We found no late-filing notices (NT 10-K or NT 10-Q) in its last 12 months of SEC filings.
Who runs Provectus Biopharmaceuticals?
Officers named in its insider filings: Edward Pershing (CEO) and Dominic Rodrigues (PRESIDENT).
Source recordIs Provectus Biopharmaceuticals making money?
Customers paid it $336,108 in the year. It lost $5.4 million. For every $1 that came in, about $17.16 went out. (Annual figures to 2025-12-31. Facts from the company's own report, not a recommendation.)
Source record